XRX SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Xerox
Xerox beat third-quarter adjusted EPS estimates, yet the same release suspended its common and preferred dividends and recorded a large noncash goodwill impairment. Investors who lost money may be entitled to seek recovery.
NEW YORK, Oct. 30, 2026 /PRNewswire/ -- Xerox Holdings Corporation (NASDAQ: XRX) shares fell sharply after the Company reported third-quarter adjusted EPS that beating analyst estimates, while suspending its common and preferred dividends and recording a $959 million noncash goodwill impairment charge. If your XRX position lost value in that sell off, you are encouraged to submit your loss details now. You may also contact Joseph E. Levi, Esq. via email at jlevi@SueWallSt.com or by telephone at (888) SueWallSt.
Despite the quarterly adjusted EPS beat, Xerox reported a 4.7% year-over-year revenue decline and sharply lower cash generation, with operating cash flow falling to $30 million from $116 million a year earlier.
SueWallSt notifies investors of a pending investigation into potential securities law violations on behalf of XRX investors.
If you lost money on Xerox, request a free review of your XRX losses or call (888) SueWallSt.
WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
Frequently Asked Questions About the XRX Investigation
Q: What is the deadline to contact Levi & Korsinsky about XRX?A: No deadline to contact Levi & Korsinsky about the XRX investigation has been announced. Contacting the firm promptly ensures your losses are considered if the investigation proceeds to legal action.
Q: Which statements are being investigated as potentially misleading?A: The investigation concerns whether Xerox made materially false or misleading statements or omissions regarding its financial condition, full-year 2026 outlook, and the assumptions underlying the valuation of its assets, including goodwill. On October 29, 2026, the Company disclosed a $959 million noncash goodwill impairment, suspended its common and preferred dividends, and significantly reduced its full-year adjusted operating income and free cash flow guidance. XRX shares fell sharply following the disclosures.
Q: When did Xerox allegedly mislead investors?A: The investigation concerns statements made before the October 29, 2026 corrective disclosure that allegedly caused investors to purchase securities at inflated prices.
Q: What do XRX investors need to do right now?A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.
Q: What documents do I need to participate?A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.
Q: What if I already sold my XRX shares -- can I still recover losses?A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought XRX and sold at a loss may still participate in the investigation.
Q: What if my XRX losses are small -- is it still worth contacting a lawyer?A: Yes. There is no minimum loss amount required to participate in the investigation.
Q: What does it cost me to participate?A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
Tel: (888) SueWallSt
Fax: (212) 363-7171
Attorney Advertising. Prior results do not guarantee similar outcomes.
View original content to download multimedia:https://www.prnewswire.com/news-releases/xrx-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-xerox-302924442.html
SOURCE SueWallSt.com
